All Videos

James Q Del Rosso, DO, Raj Chovatiya, MD, PhD, Lisa Swanson, MD, provide an overview of atopic dermatitis and review the burden of disease.

The surgical eyelid procedure is used to improve the appearance of the eyelids by removing and/or repositioning excess skin, muscle and fat. But what should you do when there’s an additional underlying defect that also contributes to eyelid appearance?

An expert in the management of basal cell carcinoma stresses the importance of early identification and engaging a multidisciplinary team in the management of patients suffering from this condition.

John Strasswimmer MD, PhD provides a recap of a panel discussion from Winter Clinical in Miami, Florida highlighting the management challenges providers face in patients with locally advanced basal cell carcinoma.

Experts in dermatology review the dosing and meal requirements need with isotretinoin administration, highlighting the impact and benefit of the novel lidose and micronized formulations.

Linda Stein-Gold, MD and Neal Bhatia, MD discuss their approach to acne management highlighting the novel utility of clascoterone cream 1% and where this fits into their treatment regimens.

Dr Raj Chovatiya discusses a recently approved therapeutic agent, spesolimab, as a valuable addition to the GPP treatment landscape.

An expert dermatologist reviews the currently available agents for treatment of GPP and highlights the unmet needs in this space.

Raj Chovatiya, MD, PhD, provides an overview of the factors he uses to lead to a diagnosis of generalized pustular psoriasis (GPP).

An expert in dermatology shares his insights into the management considerations with traditionally utilized treatments for generalized pustular psoriasis and discusses the impact of a recent approval in this space.

Dr Michael Payette discusses the patient QoL impacts and burden of generalized pustular psoriasis.

Michael Payette, MD, MBA, FAAD provides an overview of generalized pustular psoriasis, highlighting the challenges in the diagnosis of patients with this condition.

Dawn Eichenfield and Guy Webster discuss considerations relating to treating their patients with clascoterone cream 1%.

Experts in dermatology provide insight into their dosing techniques and how to approach treatment in pediatric and student athlete patients.

Drs Dawn Eichenfield and Guy Webster review their considerations when managing patients with acne, highlighting the need to treat all pathogenic of this condition and properly counseling patients about treatment options.

Dr Lawrence F. Eichenfield provides his insight into treating acne as a chronic condition and the importance of personalizing a treatment regimen.

Lawrence F. Eichenfield, MD, shares his perspectives on the management of acne vulgaris highlighting key topics that were covered in a panel discussion held at Maui Derm 2023.

Andrew F. Alexis, MD, MPH, and Benjamin N. Lockshin, MD, talk about how clinical approaches and understanding of risk/benefit profiles are evolving in light of the emerging long-term data.

Andrew F. Alexis, MD, MPH, and Benjamin N. Lockshin, MD, review the impact of the open-label extension data on the current atopic dermatitis landscape.

Thought leaders discuss the importance of rapid onset of action in atopic dermatitis care amid the backdrop of compelling 4-year efficacy and safety data for dupilumab.

Continuing their discussion about efficacy, Andrew F. Alexis, MD, MPH, and Benjamin N. Lockshin, MD, review long-term results on pruritus. Additionally, they explore data for patients who switched from weekly to every-other-week dupilumab treatment.

Brett King, M.D, Ph.D and Alexandra Golant, M.D summarize their thoughts on optimizing treatment outcomes for patients suffering from atopic dermatitis with the JAK inhibitor class.

Experts in atopic disease management review the efficacy and safety data of the JAK inhibitor class, highlighting the importance of time to treatment response and itch reduction.

Drs Alexandra Golant and Brett King discuss the role that atopic disease severity and treatment resistance play in the selection of oral vs systemic treatment for their patients.

Brett King, M.D, Ph.D and Alexandra Golant M.D comment on their considerations on the management of patients suffering from atopic dermatitis, highlighting the importance of body surface area and patient preference in treatment selection.

Andrew F. Alexis, MD, MPH, and Benjamin N. Lockshin, MD, discuss the relevance of the 4-year efficacy data for dupilumab in adults with moderate to severe atopic dermatitis, with a focus on IGA and EASI scores.

Continuing their discussion about safety, Andrew F. Alexis, MD, MPH, and Benjamin N. Lockshin, MD, take a closer look at conjunctivitis data from the long-term use of dupilumab

In this week’s Pointers with Dr Portela, the 208SkinDoc interviews the founder of dermstore.com.

Andrew F. Alexis, MD, MPH, and Benjamin N. Lockshin, MD, review the design of the LIBERTY-AD open-label extension trial and share clinical context regarding safety findings.

Thought leaders share strategies for talking to patients about the importance of treatment adherence in the long-term management of atopic dermatitis.